906674-56-4

Upstream product

• 1428-66-6 2-(((8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl)oxy)acetic acid 
• 143783-29-3 Boc-Gly-Asp(OBzl)-Ser(Bzl)-OBzl 
• 63024-02-2 Boc-Asp(OBzl)-Ser(Bzl)-OBzl 
• 246516-47-2 Boc-Arg(Nω-NO2)-Gly-Asp(OBn)-Ser(Bn)-OBn 
• 1279028-21-5 (S)-benzyl 2-amino-3-(benzyloxy)propanoate hydrochloride 
• 41164-32-3 3-ethyloxycarbonylmethylenoxyestrone 
• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 53-16-7 Estrone 

Relevant academic research and scientific papers

3D QSAR of novel estrogen-RGD peptide conjugates: Getting insight into structural dependence of anti-osteoporosis activity and side effect of estrogen in ERT

To explore the structural dependence of the oral potency and side effect of estrogen-RGD peptide conjugates, here six novel conjugates were prepared via introducing RGD-tetrapeptides into both 3- and 17-positions of estradiol, and introducing RGD-octapept

Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates

To improve the specificity and potency of estrogen replacement therapy therapeutics while also minimizing the side effects such as bone resorption and thickening of the uterine wall, a series of novel estrogen-derived conjugates estradiol-3-RGD, estradiol